A previous study suggested an increase in the abundance of AP-1 and an increase in the levels of IFNγ in ER-negative breast cancer, whereas AP-1 levels were not correlated with PR status, tumor grade, tumor size, or lymph node status (40). The gene discussed is IFNG; the disease is neoplasm.